GENEVA, June 16 -- DANATLAS PHARMACEUTICALS CO., LTD. (Suite 101, Floor 2, Building 2-4A, 7#, Liangshuihe 1st Street, BDADaxing District, Beijing 100176) filed a patent application (PCT/CN2024/136593) for "COMBINATION OF POLQ INHIBITOR AND ANTI-CANCER THERAPEUTIC AGENT" on Dec 04, 2024. With publication no. WO/2025/119195, the details related to the patent application was published on Jun 12, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ZHOU, Wenlai (Suite 101, Floor 2, Building 2-4A, 7#, Liangshuihe 1st Street, BDADaxing District, Beijing 100176), ZHUO, Jincong (Suite 101, Floor 2, Build...